Several studies have demonstrated that overexpression of IFITMs could inhibit virus entry and infection of a variety of virus families (including orthomyxoviridae and flDvLvLruses in cell culture systems [2,3]. Over-expression of IFITM1, IFITM2 or IFITM3 restricted early viral replication. On the contrary, knock-down of IFITM3 stimulated LnfluenzD A virus replication [4]. Researchers reported that IFITM3 is required for IFNα-induced anti-viral defense and restricts LnfluenzD A virus infection at viral entry and early-stage of virus life cycle. Knockdown of IFITM3 dampen 40%-70% of IFN's anti-viral eوٴect. Нus, IFITM proteins are critical for the innate immunity to LnfluenzD A virus mediated by IFNs [5]. IFITMs have been demonstrated to suppress the replication of several flDvLvLruses including West Nile virus, dengue virus, hepatitis C virus and Zika virus [4]. IFITM1 and IFITM3 inhibit ZIKV infection at early stage of the viral life cycle. In addition, IFITM3 could inhibit ZIKV-induced cell death [6]. Another IFITMs superfamily member TMEM2 has been found to inhibit HBV infection by activating the Jak/STAT signaling pathway [7]. Notably, these restricted viruses were all encapsulated, containing the ssRNA genome, and were reported to enter cells by membrane fusion DÑ–er endocytosis. However, some retroviruses, such as HIV-1 and Moloney leukaemia virus and Bunyaviridae, Crimean–Congo haemorrhagic fever virus, are obviously not Dوٴected by IFITMs. In the past studies, IFITMs were not shown to inhibit HIV-1 infection [4]. However, recent studies have reported that IFITM2 and IFITM3 could interact with HIV-1 Env protein in viral producer cells, leading to impaired Env processing and virion incorporation [8]. Meanwhile, some evidence showed that IFITM3 could also limit Non-enveloped Reoviridae, reovirus replication, suggesting that IFITMs Dوٴected a variety of viruses, not limited to viruses with envelopes [9].

Journal of Antivirals & Antiretrovirals is using Editorial Manager System for quality in review process. Editorial Manager is an online manuscript submission, review and tracking systems used by most of the best open access journals. Review processing is performed by the editorial board members of journal or outside experts; at least two independent reviewers approval followed by editor's approval is required for acceptance of any citable manuscript.

Send your manuscript at www.longdom.org/submissions/antivirals-antiretrovirals.html or as an e-mail attachment to our Editorial Office at [email protected]